Acoltremon ophthalmic solution effectively increases tear production for dry eye disease, demonstrating benefits and a favorable safety profile in clinical trials.
Cassandra R. Doyno, PharmD, BCPS
Advertisement
Articles by Cassandra R. Doyno, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Hydrogel-Based Platforms for Chronic Wounds Help Address Infection
2
Some Providers Prescribe Unapproved Retatrutide for Weight Loss at Alarming Rate
3
FDA Warns of Kidney Stone, Injury Risk in Use of OTC Weight-Loss Drug Orlistat
4
FDA Approves Lebrikizumab for 8 Week Maintenance of Atopic Dermatitis
5